|Year : 2018 | Volume
| Issue : 19 | Page : 2371-2372
Giant Axonal Neuropathy with Unusual Neuroimagings Caused by Compound Heterozygous Mutations in GAN Gene
Shuang Cai, Jie Lin, Yi-Qi Liu, Jia-Hong Lu, Chong-Bo Zhao
Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
|Date of Submission||27-Apr-2018|
|Date of Web Publication||21-Sep-2018|
Dr. Jie Lin
Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Cai S, Lin J, Liu YQ, Lu JH, Zhao CB. Giant Axonal Neuropathy with Unusual Neuroimagings Caused by Compound Heterozygous Mutations in GAN Gene. Chin Med J 2018;131:2371-2
|How to cite this URL:|
Cai S, Lin J, Liu YQ, Lu JH, Zhao CB. Giant Axonal Neuropathy with Unusual Neuroimagings Caused by Compound Heterozygous Mutations in GAN Gene. Chin Med J [serial online] 2018 [cited 2018 Dec 9];131:2371-2. Available from: http://www.cmj.org/text.asp?2018/131/19/2371/241804
To the Editor: Giant axonal neuropathy (GAN) is a rare neurodegenerative disease caused by recessive mutations in GAN gene encoding gigaxonin. Nerve pathology of GAN shows typical giant axon with accumulating intermediate filaments. The disease is progressive with impairments in both peripheral and central nervous system. Here, we reported a case presenting gait disturbance, giant axon in nerve biopsy, and abnormalities in brain magnetic resonance imaging (MRI).
A 13-year-old girl presented progressive gait disturbance for 7 years. She had a normal physical and cognitive developmental milestone before age 3. Thereafter, she showed motor retrogradation with slow running, gait imbalance, and exercise intolerance. She received Achilles tendon lengthening surgery at the age of 9. During the past 2 years, she felt numbness in distal lower limbs and difficult in doing buttons and using chopsticks. She was the first child of healthy nonconsanguineous parents with no family history of neuromuscular disorders.
On examination, she had kinky hair, bilateral pes cavus, and hammer toes. Neurological examination revealed normal mini-mental state examination score of 30, vertical and horizontal end-gaze nystagmus. Symmetrical distal muscle atrophy was observed in both lower limbs. Muscle strengths were graded 4/5 distally of the upper limbs and 3/5 distally of the lower limbs. Tendon reflexes were normal in upper limbs, but absent in lower limbs. The superficial sensation was decreased in distal upper and lower limbs, while deep sensation was decreased in distal lower limbs. The patient had impaired finger-to-nose tests, positive Holmes rebound phenomena and mildly impaired alternating movements. and heel-to-knee-to-shin tests. Romberg's test was positive. Bilateral Babinski signs were found positive. Her gait was wide-based with foot drop, and she could neither walk on her toes nor heels.
Nerve conduction velocity studies indicated predominantly axonal sensorimotor neuropathy. Full spinal X-ray showed scoliosis [Figure 1]c. Brain MRI revealed lesions around the fourth ventricle [Figure 1]a and [Figure 1]b. Nerve biopsy showed moderate myelinated nerve fiber loss, several regenerative clusters, and scattered giant axons. Neurofilament accumulation in giant axons was detected by electron microscope [Figure 1]d–1f].
|Figure 1: (a and b) Brain MRI showed signal hyperintensity in cerebellar and the bottom of the fourth ventricle on FLAIR (white arrows). (c) Spinal X-ray revealed scoliosis. (d) Giant axon in nerve biopsy by toluidine blue staining ×400 (red arrow). (e) The axon diameter was 20.39 μm by electron microscope. (f) Neurofilaments were fulfilled in the giant axon. FLAIR: Fluid-attenuated inversion recovery; MRI: Magnetic resonance imaging.|
Click here to view
Next-generation sequencing was performed. She had compound heterozygous mutations which were inherited from her father and mother (c.1174G>A [p.E392K] and c.1634G>A [p.R545H] mutations in GAN gene), respectively. Mutation of c.1174G>A was predicted to be pathogenic by SIFT, PolyPhen-2, and mutation taste. Meanwhile, the mutation was highly conserved among different species. The mutation of c.1634G>A was reported in GAN patient associated with distal limb weakness and generalized areflexia.
Giant axonal neuropathy caused by GAN gene mutation is a rare neurodegenerative disease. GAN gene encodes gigaxonin protein which plays an important role in cytoskeleton formation by stabilizing microtubule network. Till now, there are more than 80 cases of GAN mutant patients reported in literature. The initial symptoms of GAN include kinky hair, progressively walking disturbance or cerebella, and cognitive impairments. White matter changes on brain MRI have been reported, in many cases, diffuse or scattered, supratentorial or infratentorial. However, normal brain MRI is also commonly seen., Other changes include cerebral and/or cerebellar and/or brainstem atrophy. The brain MRI of reported patient with homozygous c.1634G>A mutations showed Arnold-Chiari I malformation rather than white matter changes. The presence of giant axon with accumulation of neurofilaments and axonal spheroids is the hallmarks in nerve biopsy. Our patient presented typical progressive sensorimotor neuropathy and cerebellar ataxia. Brain MRI showed abnormal signals along the bottom of the fourth ventricle which was typically seen in neuromyelitis optica (NMO) and in the cerebellum. However, this type of lesion was not commonly reported in GAN before and made it necessary to differentiate GAN from NMO or Wernicke disease on brain MRI.
Giant axonal neuropathy caused by mutations in GAN gene should be taken into consideration for patients with early-onset, progressive sensorimotor axonal neuropathy, and central nervous system abnormality. Giant axons found in nerve biopsy, and gene test can help in making the diagnosis.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
This work is supported by the National Natural Science Foundation of China (No. 81401035), and Shanghai Health and Family Planning Commission key projects (No. 15DZ1208002).
Conflicts of interest
There are no conflicts of interest.
| References|| |
Koop O, Schirmacher A, Nelis E, Timmerman V, De Jonghe P, Ringelstein B, et al.
Genotype-phenotype analysis in patients with giant axonal neuropathy (GAN). Neuromuscul Disord 2007;17:624-30. doi: 10.1016/j.nmd.2007.03.012.
Bomont P, Koenig M. Intermediate filament aggregation in fibroblasts of giant axonal neuropathy patients is aggravated in non dividing cells and by microtubule destabilization. Hum Mol Genet 2003;12:813-22. doi: 10.1093/hmg/ddg092.
Johnson-Kerner BL, Roth L, Greene JP, Wichterle H, Sproule DM. Giant axonal neuropathy: An updated perspective on its pathology and pathogenesis. Muscle Nerve 2014;50:467-76. doi: 10.1002/mus.24321.
Nalini A, Gayathri N, Yasha TC, Ravishankar S, Urtizberea A, Huehne K, et al.
Clinical, pathological and molecular findings in two siblings with giant axonal neuropathy (GAN): Report from India. Eur J Med Genet 2008;51:426-35. doi: 10.1016/j.ejmg.2008.05.006.
Tazir M, Nouioua S, Magy L, Huehne K, Assami S, Urtizberea A, et al.
Phenotypic variability in giant axonal neuropathy. Neuromuscul Disord 2009;19:270-4. doi: 10.1016/j.nmd.2009.01.011.